D. A. Vallera

558 total citations
16 papers, 437 citations indexed

About

D. A. Vallera is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, D. A. Vallera has authored 16 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 9 papers in Oncology and 4 papers in Hematology. Recurrent topics in D. A. Vallera's work include CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (8 papers) and Toxin Mechanisms and Immunotoxins (7 papers). D. A. Vallera is often cited by papers focused on CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (8 papers) and Toxin Mechanisms and Immunotoxins (7 papers). D. A. Vallera collaborates with scholars based in United States, Germany and Sweden. D. A. Vallera's co-authors include David M. Neville, Jeffrey S. Miller, Richard J. Youle, Ralph Quinones, John H. Kersey, A. H. Filipovich, Michelle Gleason, Bruce R. Blazar, Martin Felices and Robert R.M. Gifford and has published in prestigious journals such as The Lancet, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

D. A. Vallera

16 papers receiving 411 citations

Peers

D. A. Vallera
Elizabeth Taras United States
Joerg Uwe Schmohl Germany
RC Stong United States
Toshiyuki Itaya Japan
Kristin Mentz Germany
Kathryn Ruisaard United States
Rosanna M. McEwen-Smith United Kingdom
Thelma M. Watson United States
ES Vitetta United States
Kirsten Nikolajsen Denmark
Elizabeth Taras United States
D. A. Vallera
Citations per year, relative to D. A. Vallera D. A. Vallera (= 1×) peers Elizabeth Taras

Countries citing papers authored by D. A. Vallera

Since Specialization
Citations

This map shows the geographic impact of D. A. Vallera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. A. Vallera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. A. Vallera more than expected).

Fields of papers citing papers by D. A. Vallera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. A. Vallera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. A. Vallera. The network helps show where D. A. Vallera may publish in the future.

Co-authorship network of co-authors of D. A. Vallera

This figure shows the co-authorship network connecting the top 25 collaborators of D. A. Vallera. A scholar is included among the top collaborators of D. A. Vallera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. A. Vallera. D. A. Vallera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Miller, Jeffrey S., Martin Felices, D. A. Vallera, et al.. (2022). 17P Driving NK cell immunotherapy against NSCLC, in the context of hypoxia, using tri-specific engagers. Annals of Oncology. 33. S10–S10. 1 indexed citations
2.
3.
Vallera, D. A., Angela R. Manser, Sanil Bhatia, et al.. (2021). CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL. Cancer Immunology Immunotherapy. 70(12). 3701–3708. 31 indexed citations
4.
5.
Davis, Zachary, Todd Lenvik, Louis S. Hansen, et al.. (2016). A Novel HIV Envelope Bi-Specific Killer Engager Enhances Natural Killer Cell Mediated ADCC Responses Against HIV-Infected Cells. Blood. 128(22). 2517–2517. 10 indexed citations
6.
7.
Miller, Jeffrey S., Ron McElmurry, Xianzheng Zhou, et al.. (2015). Trispecific Killer Engagers (TriKEs) that contain IL-15 to make NK cells antigen specific and to sustain their persistence and expansion. Blood. 126(23). 232–232. 10 indexed citations
8.
Vallera, D. A., Yongqian Shu, Y-H. Chen, et al.. (2008). Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft model. Gut. 57(5). 634–641. 23 indexed citations
9.
10.
Vallera, D. A.. (2002). Targeting Urokinase-Type Plasminogen Activator Receptor on Human Glioblastoma Tumors With Diphtheria Toxin Fusion Protein DTAT. JNCI Journal of the National Cancer Institute. 94(8). 597–606. 76 indexed citations
11.
Frankel, Arthur E., Bayard L. Powell, D. A. Vallera, & David M. Neville. (2001). Chimeric fusion proteins--diphtheria toxin-based.. PubMed. 2(9). 1294–301. 6 indexed citations
12.
Mathur, Ambika, et al.. (1995). Effect of IL-7 or IL-4 on reconstitution of donor lymphoid cells in congenic murine bone marrow transplantation.. PubMed. 16(1). 119–24. 5 indexed citations
13.
Filipovich, A.H., D. A. Vallera, Philip B. McGlave, et al.. (1990). T CELL DEPLETION WITH ANTI-CD5 IMMUNOTOXIN IN HISTOCOMPATIBLE BONE MARROW TRANSPLANTATION. Transplantation. 50(3). 410–414. 35 indexed citations
14.
Kersey, John H., D. A. Vallera, A. H. Filipovich, et al.. (1985). Monoclonal Antibodies and Immunotoxins in Bone Marrow Transplantation: Purging Marrow of ALL or GVHD Cells with Preservation of Stem Cells. Hämatologie und Bluttransfusion. 29. 34–38. 4 indexed citations
15.
Filipovich, A. H., Richard J. Youle, David M. Neville, et al.. (1984). EX-VIVO TREATMENT OF DONOR BONE MARROW WITH ANTI-T-CELL IMMUNOTOXINS FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE. The Lancet. 323(8375). 469–472. 130 indexed citations
16.
Gifford, Robert R.M. & D. A. Vallera. (1980). Cimetidine induced augmentation of murine cell mediated cytotoxicity after in vitro and in vivo treatment. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 39. 924. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth Taras Breakdown of academic impact, for papers by Joerg Uwe Schmohl Breakdown of academic impact, for papers by RC Stong Breakdown of academic impact, for papers by Toshiyuki Itaya Breakdown of academic impact, for papers by Kristin Mentz Breakdown of academic impact, for papers by Kathryn Ruisaard Breakdown of academic impact, for papers by Rosanna M. McEwen-Smith Breakdown of academic impact, for papers by Thelma M. Watson Breakdown of academic impact, for papers by ES Vitetta Breakdown of academic impact, for papers by Kirsten Nikolajsen
Rankless by CCL
2026